What’s important to patients in a non-curative setting?

Bookmark and Share
Sorry, this item is currently unavailable.
Published: 14 Jul 2017
Views: 1431
Rating:
Save
Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Dr Collins speaks at the 'measuring success in indolent disease' session during BSH 2017 in Brighton, UK. 

Collins discusses 'What’s important to patients in a non-curative setting?'

The content available here was filmed at a Roche Products Limited promotional symposium and contains discussion of Roche medicines.